Polysaccharide microparticles as an oral vaccine platform: proof-of-concept in male rats using a GnRH-targeting fusion antigen - Quiz - MDSpire

Polysaccharide microparticles as an oral vaccine platform: proof-of-concept in male rats using a GnRH-targeting fusion antigen

  • By

  • Maximiliano Wilda

  • Maria Victoria Rocca

  • M. Solana Pesca

  • Pablo Rafael Grigera

  • June 10, 2026

  • 0 min

Share

Original Source(s)

Polysaccharide microparticles as an oral vaccine platform: proof-of-concept in male rats using a GnRH-targeting fusion antigen

  • by Maximiliano Wilda, Maria Victoria Rocca, M. Solana Pesca, Pablo Rafael Grigera

  • June 10, 2026

Related Content

Differences in clinical features and prognosis between hypertriglyceridemia and other causes of acute pancreatitis: a dual perspective based on metabolic disorders and inflammatory response

Assessment of the aggregate index of systemic inflammation in dyslipidemia with dry eye disease: a retrospective case-control

Systemic lupus erythematosus–driven accelerated atherosclerosis: the immune–metabolic–vascular axis and therapeutic implications